Kaletra Solution
Product Images NDC 0074-3956

6 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 0074-3956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bsa (Kaletra Tablets And Oral Solution Spl 01)

Bsa (Kaletra Tablets And Oral Solution Spl 01)
An illustration showing a formula for calculating body surface area (BSA) in square meters using height in centimeters and weight in kilograms, with a specific divisor of 3600 under the square root.*
FDA Label Image

Lopinavir Has The Following Structural Formula: (Kaletra Tablets And Oral Solution Spl 02)

Lopinavir Has The Following Structural Formula: (Kaletra Tablets And Oral Solution Spl 02)
Chemical structure diagram of the active ingredient in Kaletra, showing the molecular arrangement of atoms and bonds in the compound.*
FDA Label Image

Ritonavir Has The Following Structural Formula: (Kaletra Tablets And Oral Solution Spl 03)

Ritonavir Has The Following Structural Formula: (Kaletra Tablets And Oral Solution Spl 03)
Chemical structure of the active ingredient in Kaletra, illustrating the molecular arrangement with labeled atoms and bonds of the compound.*
FDA Label Image

Ndc 0074-3956-46 Kaletra® Lopinavir And Ritonavir Oral Solution 80 mg /20 mg Per mL 160 mL Alert: Find Out About Medicines That Should Not Be Taken With Kaletra Attention Pharmacist: Do Not Cover Alert Box Or Expiration Date With Pharmacy Label. Store And Dispense In Original Container.dispense The Enclosed Medication Guide To Each Patient.rx Only Abbvie (Kaletra Tablets And Oral Solution Spl 04)

Ndc 0074-3956-46 Kaletra® Lopinavir And Ritonavir Oral Solution 80 mg /20 mg Per mL 160 mL Alert: Find Out About Medicines That Should Not Be Taken With Kaletra Attention Pharmacist: Do Not Cover Alert Box Or Expiration Date With Pharmacy Label. Store And Dispense In Original Container.dispense The Enclosed Medication Guide To Each Patient.rx Only Abbvie (Kaletra Tablets And Oral Solution Spl 04)
Kaletra tablet label showing the strengths 200 mg/50 mg of Lopinavir and Ritonavir. The label includes a warning alert about medicines that should not be taken with Kaletra, instructions for pharmacists, and storage conditions. It notes the package contains 120 tablets and is labeled by AbbVie Inc.*
FDA Label Image

Ndc 0074-4014-12 Kaletra®(lopinavir And Ritonavir) Tablets 200 mg / 50 mg 120 Tabletsalert: Find Out About Medicines That Should Not Be Taken With Kaletra®attention Pharmacist: Do Not Cover Alert Box With Pharmacy Label. Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Kaletra Tablets And Oral Solution Spl 05)

Ndc 0074-4014-12 Kaletra®(lopinavir And Ritonavir) Tablets 200 mg / 50 mg 120 Tabletsalert: Find Out About Medicines That Should Not Be Taken With Kaletra®attention Pharmacist: Do Not Cover Alert Box With Pharmacy Label. Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Kaletra Tablets And Oral Solution Spl 05)
Kaletra 200 mg / 50 mg tablets label displaying active ingredients lopinavir and ritonavir. Container holds 120 tablets. Label includes warnings about drug interactions with Kaletra and pharmacist instructions. Storage and dispensing directions are provided. Manufactured by AbbVie Inc.*
FDA Label Image

Ndc 0074-3008-60 Kaletra®(lopinavir And Ritonavir) Tablets 100 mg / 25mg 60 Tablets Alert: Find Out About Medicines That Should Not Be Taken With Kaletra®attention Pharmacist: Do Not Cover Alert Box With Pharmacy Label. Dispense The Accompanying Medication Guide To Each Patient Rx Only Abbvie (Kaletra Tablets And Oral Solution Spl 06)

Ndc 0074-3008-60 Kaletra®(lopinavir And Ritonavir) Tablets 100 mg / 25mg 60 Tablets Alert: Find Out About Medicines That Should Not Be Taken With Kaletra®attention Pharmacist: Do Not Cover Alert Box With Pharmacy Label. Dispense The Accompanying Medication Guide To Each Patient Rx Only  Abbvie (Kaletra Tablets And Oral Solution Spl 06)
Kaletra tablets label featuring the active ingredients Lopinavir and Ritonavir with a strength of 100 mg/25 mg per tablet. The label shows the package contains 60 tablets and specifies storage instructions between 20°C to 25°C. It includes patient and pharmacist warnings, the AbbVie Inc. labeler, and packaging details with barcodes and lot information placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.